Elicio Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Elicio Therapeutics, Inc. has filed 371 SEC EDGAR filings since 04 Mar 2014

SEC filing history

Showing 226-250 of 371 matching filings.

Per page
25
Current page
10
425 File 001-39990

425

Filing date
17 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39990

8-K

Filing date
15 Aug 2022
Reporting date
15 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39990

8-K

Filing date
25 Jul 2022
Reporting date
25 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jul 2022
Reporting date
01 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39990

8-K

Filing date
29 Jun 2022
Reporting date
29 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Jun 2022
Reporting date
09 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Jun 2022
Reporting date
09 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Jun 2022
Reporting date
09 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Jun 2022
Reporting date
09 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
27 May 2022
Reporting date
09 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
27 May 2022
Reporting date
09 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 May 2022
Reporting date
25 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 May 2022
Reporting date
20 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-264994

424B5

Filing date
24 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-264994

424B3

Filing date
24 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-264994

EFFECT filing

Filing date
23 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2022
Reporting date
19 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
19 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
19 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93548

SC 13G

Filing date
19 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .